Norges Bank 4 D Molecular Therapeutics, Inc. Transaction History

Norges Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2024	BUY	$15.45 - $23.19 $4.54 Million - $6.82 Million	294,000 New	294,000 $5.05 Million
Q4 2022 Feb 14, 2023	BUY	$6.85 - $25.46 $2.01 Million - $7.49 Million	294,000 New	294,000 $6.53 Million
Q1 2021 May 07, 2021	SELL	$35.94 - $52.67 $179,700 - $263,350	-5,000 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$38.43 - $47.36 $192,150 - $236,800	5,000 New	5,000 $207,000

144

57.7M

137K

111K

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $252M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.